secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2026-09-14T12:30:19+00:00
Accession:  0001411690-26-000046
Event type: other
Sentiment:  neutral
Materiality: 0.12
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano CEO presents at H.C. Wainwright conference; no financial disclosures in furnished text
--------------------------------------------------------------------------------

- Al Luderer, Chairman and Interim CEO, presented September 14, 2026 at H.C. Wainwright 28th Annual Global Investment Conference.
- Furnished presentation (Exhibit 99.1) contains no specific financials, guidance, or operational updates in the available text.
- Stock trades on Nasdaq Capital Market under BNGO; company based in San Diego, CA.
- Filing is a routine investor-relations disclosure; no new quantitative data disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000046/0001411690-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000046/bngo-20260914.htm
  HTML page:      https://secwatch.observer/filing/0001411690-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer